Best GLP-1 Providers of 2026: Ranked and Reviewed

Finding a GLP-1 provider sounds simple until you actually try. Prices range from $133 to over $1,000 a month depending on the medication type, and dozens of telehealth companies have entered the market since semaglutide became a household name. Sorting out the real differences takes time most people don't have. The single most important distinction is whether a provider offers compounded or brand-name GLP-1s. Compounded medications contain the same active ingredient but are not FDA-approved as finished products, and the price difference is dramatic. This guide ranks the best GLP-1 providers of 2026 based on cost, medication access, support quality, and how well they handle insurance, so you can compare them side by side before committing.

Last verified: 2026-07-06 by RxPickr Editorial Team. Every monthly price below was confirmed against the provider's public pricing page or a completed intake quote in our July 2026 pricing refresh. We re-verify pricing monthly. Our full methodology is at How we rate providers.

Quick comparison: top GLP-1 providers at a glance

Provider (domain)	Best for	Starting price (verified July 2026)	Medication type
Hims (hims.com)	Brand-name Novo Nordisk catalog (no compounded)	From $149/mo medication + $149/mo membership	Brand Wegovy (pill + pen), Foundayo, Zepbound, Ozempic
Hers (forhers.com)	Brand-name catalog for women	From $149/mo medication + $149/mo membership	Brand Wegovy, Zepbound, Foundayo, Ozempic, Mounjaro
Ro (ro.co)	Insurance coordination	$149/mo + meds (or $74/mo annual); first-month medication from $149, ongoing $199–$449/mo	Brand Wegovy (pill + pen), Zepbound KwikPen, Foundayo (brand-name only)
Henry Meds (henrymeds.com)	All-inclusive, no membership	$297/mo (sema injection, mo-to-mo) or $197/mo (12-mo paid in full)	Compounded sema (injection + sublingual + oral), liraglutide, oral tirz tablets
TrimRx (trimrx.com)	Flat-rate compounded	$199/mo (sema) or $349/mo (tirz), flat at every dose; 12-mo prepay from $174/$283	Compounded semaglutide + tirzepatide
Oak Longevity (oaklovesyou.com)	Lowest headline compounded rate	From $133/mo (sema) or $199/mo (tirz), flat at every dose (multi-month plan; month-to-month higher)	Compounded semaglutide + tirzepatide (compounded only)
Eden (eden.health)	Flat-dose compounded pricing	$99/mo medication + $99/mo membership ($39 first month) = ~$198/mo	Compounded sema + tirz, brand Wegovy/Zepbound at cash retail
Shed (tryshed.com)	Multi-format compounded (injection, sublingual, lozenge)	From $149/mo (Microdose)	Compounded sema + tirz, brand Wegovy/Zepbound/Foundayo
Enhance.MD (enhance.md)	Cheapest compounded tirzepatide (Microdose)	$212/mo (sema) or $280/mo (tirz), 12-mo plan; Microdose Tirz $169/mo	Compounded semaglutide + tirzepatide
PlushCare (plushcare.com)	Insured patients	$19.99/mo + meds	Brand-name full formulary
Found (joinfound.com)	Full program + insurance check	From $169/mo all-in (12-mo plan, compounded medication included); ~$289/mo month-to-month	10+ medications: compounded sema/tirz/liraglutide + brand Wegovy, Zepbound, Foundayo
Noom Med (noom.com/med)	Behavioral coaching	$79/mo first month (currently discounted), $199/mo ongoing (Microdose)	Compounded semaglutide + tirzepatide
LillyDirect (lilly.com/lillydirect)	Brand tirzepatide + Foundayo, manufacturer-direct	Foundayo from $149/mo; Zepbound $299–$449/mo	FDA-approved Zepbound + Foundayo
NovoCare Pharmacy (novocare.com)	Brand semaglutide, manufacturer-direct	Wegovy pill from $149/mo; Wegovy pen $199/mo intro / $349/mo ongoing; Ozempic $349–$499/mo	FDA-approved Wegovy + Ozempic only (requires existing Rx)
Mochi Health (joinmochi.com)	Flat pricing + dietitian access	$178/mo (sema) or $278/mo (tirz)	Compounded + brand options
WeightWatchers Clinic (weightwatchers.com/us/clinic)	Group coaching + GLP-1	$74/mo + meds	Brand Wegovy, oral semaglutide

Prices are as of July 2026 per each provider's website (verified post-intake where applicable) and may change.

What's new in 2026: Foundayo (orforglipron)

The FDA approved Eli Lilly's Foundayo, the first oral GLP-1 receptor agonist for chronic weight management, on April 1, 2026 (FDA approval announcement). It's a once-daily pill that doesn't require food or water restrictions. The cheapest verified path is LillyDirect at $149/month for the 0.8mg starter dose, direct from Eli Lilly with no telehealth platform fees — but it's fulfillment-only, so you need an existing prescription from any licensed provider. As of July 2026, five telehealth providers also stock Foundayo with prescribing included: Found, Hers, Hims, Ro, and Shed, all at $149/month medication for the 0.8mg starter dose (escalating to $199/mo at 2.5mg and $299/mo at 5.5mg–17.2mg). Total monthly cost depends on each provider's membership structure: Found at $248/mo total ($149 medication + $99 CORE membership on 12-mo plan), Hers/Hims at $298/mo total ($149 + $149 membership), Shed at $274/mo total ($149 + $125 Shed Membership), and Ro at $298/mo first-month total ($149 + $149 membership), with Ro's medication escalating to $199–$299/mo at higher doses. For patients who want an FDA-approved oral GLP-1 without the regulatory ambiguity of compounded formulations, Foundayo is the most affordable starting price currently available.

---

Hims

Hims entered the GLP-1 market with an official Novo Nordisk partnership and now offers a broad brand-name catalog. The catalog as of July 2026: Wegovy pill ($149/mo medication), Wegovy pen ($199/mo), Foundayo ($149/mo starter, escalating by dose), Zepbound (vial or KwikPen, $299/mo starter), and Ozempic ($199/mo, off-label for weight loss). All require a $149/month Hims Weight Loss Membership ($39 first month). Hims discontinued oral compounded semaglutide in Q1 2026 after striking a partnership with Novo Nordisk to sell brand-name GLP-1s instead. It suits patients who want brand-name credibility and a low-friction app experience, but Hims does not actively help with insurance prior authorization. See how it stacks up in our Hims vs Ro comparison.

---

Hers

Hers is the women's-focused arm of the Hims & Hers brand and operates under the same Novo Nordisk partnership. The catalog is entirely brand-name as of July 2026: Wegovy pill ($149/mo medication), Wegovy pen ($199/mo), Foundayo ($149/mo starter), Zepbound vial or KwikPen ($299/mo starter), Ozempic ($199/mo, off-label for weight loss), and Mounjaro ($1,899/mo, essentially retail since Lilly has no self-pay program for Mounjaro). All require the $149/month Hers Weight Loss Membership ($39 first month). Hers discontinued its $69/month compounded oral semaglutide pill in March 2026 after the Novo Nordisk partnership, so the platform is no longer a compounded option.

---

Ro

Ro's main advantage over most competitors is built-in insurance coordination. The care team actively helps patients navigate prior authorization for brand-name GLP-1s including Wegovy and Zepbound, which most platforms leave entirely to the patient. Catalog as of July 2026: Wegovy (pill or pen), Zepbound KwikPen, and Foundayo. Ro exited compounded semaglutide in 2026 and is now brand-name only, following Hims's earlier move. Pricing follows an introductory model: first-month medication runs $149 (Wegovy pill, Foundayo), $199 (Wegovy pen), or $299 (Zepbound KwikPen); ongoing rates step up to $199–$299/mo (Wegovy pill, Foundayo), $199–$399/mo (Wegovy pen), or $399–$449/mo (Zepbound KwikPen) depending on dose. Membership is $149/month month-to-month or $74/month on the annual plan; annual prepay also saves $50/month on Wegovy pill and $150/month on Wegovy pen.

---

Henry Meds

Henry Meds is a true all-inclusive provider: one flat price covers the compounded medication, medical consultations, supplies, and follow-up visits, with no separate membership fee. Pricing varies by commitment length and is published transparently on Henry Meds' programs page (July 2026). Compounded semaglutide injection runs $297/month on month-to-month, $247/month on 6-month paid in full ($1,482 upfront), and $197/month on 12-month paid in full ($2,364 upfront). Compounded liraglutide (a daily-injection alternative) is cheaper at $179/month month-to-month or $119/month on 12-month paid in full. Sublingual semaglutide is $179/month. Henry Meds does not offer compounded tirzepatide as an injection; tirzepatide is available only as oral tablets at $349/month on a 3-month subscription ($297/month if paid in full upfront). The trade-off is minimal support: Henry Meds is primarily an async prescription service with no coaching or dietitian access. Note that compounded medications are not FDA-approved as finished products.

---

TrimRx

TrimRx keeps the model simple: one all-inclusive price covers the compounded medication, medical consultation, supplies, and shipping with no hidden fees. As of July 2026, TrimRx charges a flat $199/month for compounded semaglutide and $349/month for compounded tirzepatide, the same price at every dose. The "$179" headline you may still see is a first-month rate on the month-to-month plan, which renews at $299/month for semaglutide; prepaid plans bring the effective rate down to $174–$209/month for semaglutide and $283–$316/month for tirzepatide depending on commitment length. Verify the exact plan tier at checkout. TrimRx uses a licensed compounding pharmacy. As with all compounded medications, these are not FDA-approved as finished products. TrimRx does not offer brand-name GLP-1s or insurance support.

---

Oak Longevity

Oak Longevity is an all-inclusive compounded GLP-1 platform with no membership fee, no lifetime commitment, and a credentialed clinical operation: per Oak Longevity's published clinical team page, NVP Medical Group, P.A. handles prescribing, with Michael Regan, MD (board-certified in Emergency Medicine and Obesity Medicine) as Chief Medical Officer, and NVP also staffs physicians for Wisp and Ro, so the clinical infrastructure is shared with established peers. In 2026 Oak switched to flat, all-dose pricing (verified July 2026): compounded semaglutide from $133/mo on a multi-month plan (about $167–$199/mo month-to-month) and compounded tirzepatide from $199/mo on a multi-month plan (about $233–$299/mo month-to-month), one price at every dose with no escalation as you titrate up. Compounded oral semaglutide is also available at $245 per 4-week supply. Oak no longer sells brand-name GLP-1s; it lists their roughly $1,000–$1,400/mo retail cost only as a price comparison. Oak is available in 45 states; California is excluded for compounded GLP-1s. The 503B compounding pharmacy partner is not named publicly.

---

Eden

Eden (now at eden.health after moving from tryeden.com) offers compounded semaglutide and tirzepatide on a flat-dose medication pricing model, where the medication rate stays the same as you titrate to higher doses: $99/month for compounded semaglutide and $199/month for compounded tirzepatide (verified July 2026). The catch is a change Eden made in 2026: a required Eden Membership now runs $99/month ($39 for the first month) on top of the medication price, so the real total is about $198/month for semaglutide and $298/month for tirzepatide. Eden also lists brand-name Wegovy ($1,695/mo) and Zepbound ($1,399/mo) at cash retail prices, far above manufacturer-direct paths like NovoCare and LillyDirect. Compounded medications are not FDA-approved as finished products.

---

Shed

Shed offers the widest format diversity of any provider reviewed. Compounded semaglutide injection runs $175/month on the 12-month plan ($199 on 6-month, $249 month-to-month). Compounded tirzepatide injection runs $245/month on the 12-month plan ($279 on 6-month, $349 month-to-month). A separate Microdose track holds the cheapest entry: $149/month for compounded semaglutide and $199/month for compounded tirzepatide. For patients who don't want injections, Shed cut its non-injection prices this summer: sublingual GLP-1 lozenges are now $199/month (down from $299) and GLP-1 liquid drops are $229/month (down from $329–$419), with the drops now sold as a single product covering both semaglutide and tirzepatide. Brand-name Wegovy, Zepbound, and Foundayo are also available, all requiring an additional $125/month Shed Membership. Compounded products are not FDA-approved as finished products.

---

Enhance.MD

Enhance.MD prices compounded GLP-1s at a flat rate for every dose: $212/month for sema and $280/month for tirz on a 12-month commitment, with the same rate at every dose level. Month-to-month plans run noticeably higher (sema $249/mo, tirz $329/mo). No separate membership fee. The flat $49/$99 first-month promos from earlier in 2026 were retired; first-month discounts are now code-based (seasonal codes such as SUMMER50), so check the current offer at signup. The Elite tier combines sema and tirz at $322/month ongoing for patients who switch between molecules. Enhance.MD also offers a Microdose Tirzepatide product at $169/month (1mg/week dose), which is the cheapest verified compounded tirzepatide option in our database. Compounded medications are not FDA-approved as finished products.

---

PlushCare

PlushCare is the strongest choice for patients with insurance. It accepts Aetna, Humana, Cigna, and others, and board-certified primary care physicians handle prior authorization support. The brand-name formulary is the widest of any platform reviewed here: Wegovy, Zepbound, Saxenda, Rybelsus, Ozempic, and Mounjaro are all available. The membership is $19.99/month plus a $129 initial consultation fee (July 2026, per PlushCare website), but medication costs without insurance can reach $900–$1,400/month for brand-name GLP-1s. PlushCare does not offer compounded semaglutide or tirzepatide.

---

Found

Found takes a wider view than most GLP-1 providers. It offers a broad weight-loss medication catalog, runs a free insurance coverage check (Found contacts your insurer directly and reports back), and wraps it all in a full support program including licensed clinicians, health coaches, and a behavior change app. In 2026 Found restructured its compounded pricing into an all-in plan (verified July 2026): the GLP-1 Program now includes the compounded medication (semaglutide, tirzepatide, or liraglutide, at one flat rate across all of them and all doses) in a single price, at $169/mo on the 12-month prepaid plan, about $199/mo on the 6-month plan, or $289/mo month-to-month. The old split of a medication price plus a separate membership is retired for compounded plans. Brand-name medications still bill medication plus a CORE membership ($99/mo on the 12-month plan): Foundayo $149/mo starter ($248/mo total), Wegovy pill $198/mo ($297/mo total), Wegovy pen $248/mo ($347/mo total), and Zepbound KwikPen $348/mo ($447/mo total). Found also offers an insurance pathway from $99/mo (12-month plan) to $199/mo (month-to-month) plus a roughly $30 per-visit copay for patients with covered brand-name GLP-1s. As with all compounded options, those medications are not FDA-approved as finished products.

---

Noom Med

Noom Med is built on the premise that medication works better alongside behavioral change. The platform combines compounded GLP-1 medications with Noom's established behavioral coaching app, which addresses food psychology and habit formation. Three program tiers (July 2026, per noom.com): the Microdose GLP-1Rx track at $79/month first month (currently discounted from $99), $199/month ongoing (compounded semaglutide capped at 0.6mg dose ceiling); the standard GLP-1Rx track at $129/month first month, $279/month ongoing (full-dose compounded sema titration); and the GLP-1Rx Plus Program at $149/month first month (currently discounted from $199), $299/month ongoing (compounded tirzepatide). All include the behavioral app, clinical care, and medication in one charge with no separate subscription. Compounded medications are not FDA-approved as finished products.

---

LillyDirect

LillyDirect lets patients buy FDA-approved Zepbound (tirzepatide) and Foundayo (orforglipron) directly from Eli Lilly, bypassing third-party telehealth platforms entirely. As of July 2026, LillyDirect is the cheapest verified path for both Foundayo (the new oral GLP-1 pill, $149/mo at 0.8mg starter dose through the Foundayo Self Pay Journey Program) and Zepbound vials ($299/mo for 2.5mg, $399/mo for 5mg, $449/mo for 7.5mg–15mg within the 45-day refill window). The catch is fulfillment-only scope: no telehealth, no prescribing, no coaching, no care team. Patients need an existing prescription from any licensed provider. This is the right choice if your goal is brand-name tirzepatide or oral Foundayo at a predictable cash price with no intermediary.

---

NovoCare Pharmacy

NovoCare Pharmacy is Novo Nordisk's manufacturer-direct fulfillment program — the equivalent of LillyDirect for Wegovy and Ozempic. Patients with an existing prescription can buy at Novo's published self-pay rates without going through a telehealth platform's membership or visit fees. Pricing as of July 2026: Wegovy pill (1.5mg and 4mg) at $149/mo, Wegovy injectable pen at $199/mo for the first 2 months at starter doses ($349/mo from month 3 onward), and Ozempic at $349–$499/mo for off-label weight-loss use (with a $199/mo intro for the first 2 months at starting doses; verify on novocare.com). The catch is that NovoCare is fulfillment-only — it does not provide telehealth visits, prescribing, or care team support. Patients need to obtain a prescription from any licensed provider first, and there's no coaching, dose-management help, or follow-up clinical care included. For users who already have a stable Rx and just want the cheapest brand-name path, NovoCare is the floor on Wegovy pill pricing in our entire database.

---

How we ranked these providers

The providers above were evaluated on four criteria:

Cost and value. We looked at the true all-in monthly cost, including membership fees that are billed separately from medication. A provider charging $99 for medication plus $79 for a mandatory membership is a $178/month program, and we present it that way.

Medication access. Does the provider offer both compounded and brand-name options? Is tirzepatide available, not just semaglutide? Are delivery formats (oral vs. injectable) clearly disclosed? Providers with broader formularies scored higher.

Support and care quality. This includes asynchronous messaging, synchronous visits, registered dietitian access, behavioral coaching, and care team responsiveness. Patients who want medication only and patients who want full programs have different needs, and we tried to match each provider to the right audience.

Insurance handling. Some platforms actively assist with prior authorization, contact insurers directly, and support insured patients through the approval process. Others are self-pay only. This distinction matters a great deal for patients who have coverage they want to use.

Pricing was verified against each provider's website (and post-intake flows where applicable) in July 2026 and may change. The rankings reflect our editorial judgment, and no provider paid for placement.

---

Which provider is right for you?

If cost is your top priority and you're paying out of pocket, Oak Longevity has the lowest headline rate at $133/mo for compounded semaglutide (multi-month plan, one flat price at every dose; month-to-month runs ~$167–$199). Shed Microdose at $149/mo all-inclusive is the cheapest no-commitment rate (genuinely no separate membership). Found is next at $169/mo all-in on the 12-month plan with the compounded medication included. Mochi Health runs $178/mo total ($79 membership + $99 medication), Eden about $198/mo total ($99 medication + $99 membership), and TrimRx $199/mo flat at every dose. All use compounded semaglutide, which is not FDA-approved as a finished product but contains the same active ingredient as brand-name options. For compounded tirzepatide, Enhance.MD's Microdose Tirzepatide at $169/mo is the cheapest verified option, followed by Oak Longevity and Shed Microdose at $199/mo. Henry Meds does not offer compounded tirzepatide as an injection, only as oral tablets at $349/mo.

If you have insurance and want to use it, PlushCare is the most insurance-capable platform reviewed here, with the widest brand-name formulary and active prior auth support. Ro and Found also provide insurance coordination and are worth comparing. Prior authorization for brand-name GLP-1s can take 2–4 weeks, so start the process early.

If you want brand-name medication without insurance involvement, Hims (Wegovy pill from $149/mo or pen from $199/mo, plus the $149/mo membership), Hers (same brand-name catalog plus Foundayo and Zepbound), and LillyDirect (Zepbound direct from Eli Lilly) are the clearest self-pay brand-name options. LillyDirect's fixed-price program is particularly predictable, with $299/mo for 2.5mg vials and $449/mo for 7.5mg–15mg vials within the refill window. Found and Shed also offer brand-name options at competitive starter rates if you want a single platform for both compounded and brand-name access.

If you want coaching or behavioral support alongside medication, Found and Noom Med both wrap clinical prescribing inside a structured program. Found offers the free insurance check as a differentiator. Noom Med is the better fit if you want behavioral science integrated into the program rather than just check-ins. WeightWatchers Clinic is worth considering if you value group coaching and the WW community structure alongside your prescription.

If injections are a dealbreaker, the cheapest brand-name oral path is the Wegovy pill at Shed at $149/mo medication + $125/mo Shed Membership = $274/mo total. Hims and Hers offer the same Wegovy pill at $149/mo medication + $149/mo membership = $298/mo total. Foundayo (orforglipron) at Found ($248/mo total), Shed ($274/mo), Hers, or Hims ($298/mo) is the cheapest FDA-approved oral GLP-1 alternative at the starter dose. For compounded options, Henry Meds sublingual semaglutide at $179/mo all-inclusive is the cheapest non-injection compounded path. Shed offers sublingual lozenges ($199/mo) and liquid drops ($229/mo), both cut this summer. Clinical evidence for non-injection compounded formulations is more limited than for injections.

The right answer depends on your specific situation. A licensed healthcare provider can help you weigh medication options, review your health history, and determine whether GLP-1 therapy is appropriate for you.